Literature DB >> 29901209

Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.

Lindsey K Borton1, Kelly P Coleman2.   

Abstract

Pyrogenicity presents a challenge to clinicians, medical device manufacturers, and regulators. A febrile response may be caused by endotoxin contamination, microbial components other than endotoxin, or chemical agents that generate a material-mediated pyrogenic response. While test methods for the assessment of endotoxin contamination and some microbial components other than endotoxin are well-established, material-mediated pyrogens remain elusively undefined. This review presents the findings of literature searches conducted to identify material-mediated pyrogens associated with medical devices. The in vivo rabbit pyrogen test (RPT) is considered to be the “gold standard” for medical device pyrogenicity testing, despite the fact that few medical device-derived material-mediated pyrogens are known. In line with global efforts to reduce the use of research animals, an in vitro monocyte activation test (MAT) has the potential to replace the RPT. The MAT is used to detect substances that activate human monocytes to release cytokines. This review will also describe the potential opportunities and challenges associated with MAT adoption for the detection of material-mediated pyrogens in medical device testing.

Entities:  

Keywords:  material-mediated pyrogens; ISO 10993-11; medical devices; monocyte activation test (MAT); pyrogen test

Mesh:

Substances:

Year:  2018        PMID: 29901209     DOI: 10.14573/altex.1709221

Source DB:  PubMed          Journal:  ALTEX        ISSN: 1868-596X            Impact factor:   6.043


  1 in total

1.  First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity-Part 1: Biocompatibility Testing.

Authors:  Aura Kullmann; Debra Kridner; Steve Mertens; Mark Christianson; Dave Rosa; Camilo A Diaz-Botia
Journal:  Front Neurosci       Date:  2022-04-29       Impact factor: 5.152

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.